✦ LIBER ✦

Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group

✍ Scribed by G Giaccone; E.F Smit; M de Jonge; E Dansin; E Briasoulis; A Ardizzoni; J.-Y Douillard; D Spaeth; D Lacombe; B Baron; P Bachmann; P Fumoleau

Book ID: 116428037
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 170 KB
Volume: 40
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2003.10.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glufosfamide administered using a 1-hour

Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group

✍ E Briasoulis; N Pavlidis; C Terret; J Bauer; W Fiedler; P Schöffski; J-L Raoul; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A phase II study of S-1 monotherapy as s

A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer

✍ Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

6615 POSTER Biweekly paclitaxel as secon

6615 POSTER Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Vázquez-Estévez, S.; Fírvida, J.L.; Grande, C.; Barón, F.; Lázaro, M.; Salgado, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

9071 A phase II study of S-1 monotherapy

9071 A phase II study of S-1 monotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer, the Central Japan Lung Study Group trial 0404

✍ Nishiyama, O.; Taniguchi, H.; Hiramatsu, T.; Baba, K.; Saito, H.; Yamamoto, M.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Second-line treatment of non-small cell

Second-line treatment of non-small cell lung carcinomas with vinorelbine and ifosfamide: preliminary results of a phase II trial of the Greek Cooperative Group for Lung Cancer

✍ Papadakis, E; Kourousis, Ch; Androulakis, N; Agelaki, S; Apostolopoulou, F; Pala 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 239 KB

P-588 Biweekly docetaxel and vinorelbine

P-588 Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB